questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins atténués
Vaccins atténués : Questions médicales fréquentes
Termes MeSH sélectionnés :
Epithelial-Mesenchymal Transition
Diagnostic
2
Vaccins atténués
Agents pathogènes
Immunisation
Tests sérologiques
Efficacité des vaccins
Immunité
Symptômes
2
Réactions aux vaccins
Effets secondaires
Fièvre
Maladies infectieuses
Réactions indésirables
Vaccins
Prévention
2
Préparation à la vaccination
Antécédents médicaux
Vaccins
Immunodépression
Sécurité des vaccins
Vaccins atténués
Traitements
2
Réactions allergiques
Traitement médical
Vaccins
Antécédents médicaux
Prévention
Vaccins
Complications
2
Complications
Infections
Vaccins atténués
Surveillance médicale
Effets indésirables
Vaccins
Facteurs de risque
2
Immunodépression
Grossesse
Vaccins atténués
Allergies
Évaluation médicale
Vaccins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins atténués : Questions médicales les plus fréquentes",
"headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins atténués"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaccins atténués",
"alternateName": "Vaccines, Attenuated",
"code": {
"@type": "MedicalCode",
"code": "D014613",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Aitor Nogales",
"url": "https://questionsmedicales.fr/author/Aitor%20Nogales",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com."
}
},
{
"@type": "Person",
"name": "Charles Grose",
"url": "https://questionsmedicales.fr/author/Charles%20Grose",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA."
}
},
{
"@type": "Person",
"name": "Manish Patel",
"url": "https://questionsmedicales.fr/author/Manish%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov."
}
},
{
"@type": "Person",
"name": "Jessie R Chung",
"url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epithelial-Mesenchymal Transition (EMT).",
"datePublished": "2023-07-13",
"url": "https://questionsmedicales.fr/article/37511145",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411386"
}
},
{
"@type": "ScholarlyArticle",
"name": "Epithelial-Mesenchymal Transition (EMT) 2021.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35628655",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23105848"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/36830767",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biom13020398"
}
},
{
"@type": "ScholarlyArticle",
"name": "CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic Lesions.",
"datePublished": "2024-05-10",
"url": "https://questionsmedicales.fr/article/38727794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12105-024-01646-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Epithelial to Mesenchymal Transition in Colorectal Cancer.",
"datePublished": "2023-10-01",
"url": "https://questionsmedicales.fr/article/37834263",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241914815"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins atténués",
"item": "https://questionsmedicales.fr/mesh/D014613"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins atténués - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins atténués",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins atténués",
"description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Epithelial-Mesenchymal+Transition#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins atténués",
"description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Epithelial-Mesenchymal+Transition#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins atténués",
"description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Epithelial-Mesenchymal+Transition#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins atténués",
"description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Epithelial-Mesenchymal+Transition#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins atténués",
"description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Epithelial-Mesenchymal+Transition#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins atténués",
"description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Epithelial-Mesenchymal+Transition#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un vaccin est atténué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents."
}
},
{
"@type": "Question",
"name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après un vaccin atténué ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués causent-ils des maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée."
}
},
{
"@type": "Question",
"name": "Comment se préparer avant de recevoir un vaccin atténué ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués sont-ils sûrs pour tous ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction sévère à un vaccin atténué ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter immédiatement un professionnel de santé pour évaluer la situation."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués nécessitent-ils un traitement préventif ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un vaccin atténué ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des infections chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Les complications des vaccins atténués sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les vaccins atténués ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Vaccins atténués" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.
Publications dans "Vaccins atténués" :
Epithelial-mesenchymal transition (EMT) is a cellular process involved in many physiological and pathological conditions [...]....
Epithelial-mesenchymal transition (EMT) is a transdifferentiation process wherein epithelial cells acquire characteristics typical of mesenchymal cells [...]....
The epithelial to mesenchymal transition (EMT) is a cellular process that has been linked to the promotion of aggressive cellular features in many cancer types. It is characterized by the loss of the ...
Odontogenic lesions constitute a heterogeneous group of lesions. CLIC4 protein regulates different cellular processes, including epithelial-mesenchymal transition and fibroblast-myofibroblast transdif...
It analyzed the immunoexpression of CLIC4, E-cadherin, and Vimentin in the epithelial cells, as well as CLIC4 and α-SMA in the mesenchymal cells, of ameloblastoma (AM) (n = 16), odontogenic keratocyst...
Cytoplasmic CLIC4 immunoexpression was higher in AM and AOT (p < 0.001) epithelial cells. Nuclear-cytoplasmic CLIC4 was higher in OKC's epithelial lining (p < 0.001). Membrane (p = 0.012) and membrane...
CLIC4 seems to regulate the epithelial-mesenchymal transition, modifying E-cadherin and Vimentin expression. In mesenchymal cells, CLIC4 may play a role in fibroblast-myofibroblast transdifferentiatio...
The epithelial-mesenchymal transition (EMT) is a cellular reprogramming process that occurs during embryonic development and adult tissue homeostasis. This process involves epithelial cells acquiring ...
Epithelial to mesenchymal transition (EMT) is a complex cellular program that alters epithelial cells and induces their transformation into mesenchymal cells. While essential to normal developmental p...
Chronic rhinosinusitis (CRS) is a common condition in otorhinolaryngology. It is characterized by chronic inflammation of the nasal cavity and the sinus mucosa. However, its specific pathogenesis rema...
The study aimed to explore our understanding of how EMT contributes to the pathogenesis of CRS and to examine the role of several signaling pathways in EMT....
PubMed database was used to review the literature related to EMT in CRS pathogenesis. The following key words were used for the search strategy: CRS, sinusitis, nasal polyps, epithelial cells, EMT, dy...
EMT is widely present in the nasal mucosa of CRSwNP patients and contributes to the pathogenesis of the disease. However, there is no sufficient evidence for the existence of EMT in CRSsNP. Multiple s...
EMT is closely associated with CRS pathogenesis. Our study supports further research on epithelial EMT changes in CRS patients and provides a basis for revealing its pathogenesis and exploring new tre...
Metastasis refers to the spread of cancer cells from a primary tumor to other parts of the body via the lymphatic system and bloodstream. With tremendous effort over the past decades, remarkable progr...
In this review, we have focused on changes in the mechanical properties of cancer cells and their surrounding environment to understand the causes of cancer metastasis. Cancer cells have unique mechan...
Epithelial-to-mesenchymal transition (EMT) is a complex biological process that occurs during normal embryogenesis and in certain pathological conditions, particularly in cancer. EMT can be viewed as ...
The plasticity along the epithelial-mesenchymal transition (EMT) spectrum has been shown to be regulated by various epigenetic repertoires. Emerging evidence of local chromatin conformation changes su...
We perform Hi-C analysis and combine ChIP-seq data across cancer cell lines representing different EMT states. We demonstrate that the epithelial and mesenchymal genes are regulated distinctively. We ...
We propose a novel workflow coupling immunofluorescence and dielectrophoresis to unravel EMT heterogeneity at single-cell resolution. The predicted three-dimensional structures of chromosome 10, harbo...